Maintaining Hold on Allakos: Weighing AK006 Promise Against Clinical Setbacks
Express News | Allakos Inc : Jefferies Cuts Target Price to $0.85 From $1
Allakos GAAP EPS of -$0.30
Allakos's Promising Drug and Financial Health Garner a Buy Rating
TD Cowen Sticks to Its Hold Rating for Allakos (ALLK)
Express News | Allakos Shares Are Trading Higher After the Company Reported Better-than-expected Q2 EPS Results
Express News | Allakos Inc Q2 Shr View $-0.33 -- LSEG IBES Data
Express News | Allakos Qtrly Shr Loss $0.30
Express News | Allakos Inc: Reiterates That Restructuring Activities Will Extend Cash Runway Into Mid-2026
Allakos | 10-Q: Q2 2024 Earnings Report
Allakos 2Q Loss/Shr 30c >ALLK
Express News | Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
Express News | Allakos Q2 Net Income USD -26.676 Million
Express News | Allakos Q2 Operating Expenses USD 28.633 Million
Can Allakos (NASDAQ:ALLK) Afford To Invest In Growth?
Allakos Price Target Cut to $1.00/Share From $1.50 by Jefferies
Allakos Is Maintained at Hold by Jefferies
Jefferies Initiates Allakos(ALLK.US) With Hold Rating, Announces Target Price $1
Express News | Allakos Inc : Jefferies Cuts Target Price to $1 From $1.5
Allakos(ALLK.US) Officer Sells US$87,934.64 in Common Stock
No Data